Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis-Reference-Cited by-同舟云学术

Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis

Published:2009-04 Issue:4 Volume:60 Page:994-1005
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Andreakos Evangelos,Rauchhaus Una,Stavropoulos Athanassios,Endert Gerold,Wendisch Volkmar,Benahmed Amina S.,Giaglis Stavros,Karras James,Lee Sam,Gaus Hans,Bennett C. Frank,Williams Richard O.,Sideras Paschalis,Panzner Steffen

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24434/fullpdf

Reference48 articles.

1. Cytokines and anti-cytokine biologicals in autoimmunity: present and future;Andreakos;Cytokine Growth Factor Rev,2002

2. New therapies for treatment of rheumatoid arthritis;Smolen;Lancet,2007

3. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions;Grammer;J Clin Invest,2003

4. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand;Kawai;Nat Med,2000

5. Approaches for the sequence-specific knockdown of mRNA;Scherer;Nat Biotechnol,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma;Current Drug Delivery;2024-05-02

2. A REVIEW ON MACROPHAGES AND THE IMPACT OF PROTEASOME INHIBITORS ON RHEUMATOID ARTHRITIS;International Journal of Pharmacy and Pharmaceutical Sciences;2024-05-01

3. Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine;European Journal of Pharmaceutics and Biopharmaceutics;2024-04

4. Delivery of Rna Drugs: Beyond the Liver, More than Vaccine;2023

5. An overview of immune checkpoint therapy in autoimmune diseases;International Immunopharmacology;2022-06